Vascular Aging and Microcirculation: Physiological Aspects of Vascular Aging in the Elderly Population (VAMP-Aging)

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age60-100
SponsorNational Institute of Cardiology, Laranjeiras, Brazil

About this trial

Rising life expectancy worldwide challenges public health due to increased cardiovascular disease linked to vascular aging, where microvascular dysfunction serves as an early indicator of system-wide inflammation, or "inflammaging". The proposed study aims to validate non-invasive, high-resolution techniques, such as Laser Speckle Contrast Imaging, to identify early endothelial senescence biomarkers and map their correlation with metabolic, inflammatory, and anthropometric profiles to advance personalized, preventive translational medicine.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Absence of symptoms and history of cardiovascular and cerebrovascular diseases.

Baseline blood pressure levels within the normal range (< 140/90 mmHg, according to WHO criteria) and absence of use of antihypertensive medications.

Disqualifiers

Diabetes Mellitus: Fasting blood glucose ≥ 126 mg/dL or use of hypoglycemic agents.

Smoking: Active or quit less than 5 years ago.

Inflammatory Diseases: Autoimmune diseases, active neoplasms, or acute infectious processes.

Surgery or trauma in the last 60 days.

Trial population

An observational, cross-sectional study will be conducted, including volunteers aged ≥ 60 years, divided into two groups: elderly (60-80 years) and very elderly (\>80). Young volunteers aged between 20 and 40 years, already participants in previous studies, whose demographic and microcirculation data are in the research laboratory's database, will be included as controls. Data from the control group will be obtained from an institutional database, respecting confidentiality and anonymization, in accordance with current ethical standards.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Laser Speckle Contrast Imaging

    Diagnostic test

    Investigation of Systemic Endothelial Microvascular Function

  • Handgrip Dynamometry (Muscle Strength)

    Diagnostic test

    Serving as a marker of systemic muscle strength and sarcopenia.

  • Sit-to-Stand Test (5-Times Sit-to-Stand - 5STS)

    Diagnostic test

    This test will assess the strength and power of the lower limbs.

  • Single-Leg Balance Test

    Diagnostic test

    Failure to maintain the position (to stand on one leg) for at least 10 seconds will be correlated as a marker of frailty and risk of falls.

  • Assessment of Global Cognitive Function

    Diagnostic test

    Overall cognitive function will be assessed using the Mini-Mental State Examination.

Treatment groups

62 Participants
are divided into 2 treatment groups
Group A: elderly (60-80 years)5 interventions
Group B: very elderly (>80)5 interventions

Trial outcomes

Primary outcomes

1

Systemic (cutaneous) microcirculatory reactivity.

To analyze structural and functional changes in the microcirculation in different ages groups, with emphasis on microvascular endothelial senescence.

Time frame
up to 20 minutes

Secondary outcomes

1

Muscle Strength

Handgrip Dynamometry Maximum isometric strength will be assessed using a manual hydraulic dynamometer.

Time frame
up to 10 minutes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: